Pharmacokinetics of human growth hormone releasing factor (hGRF-44 NH2) in normal men after intravenous administration of a large range of doses

1987 ◽  
Vol 32 (5) ◽  
pp. 507-513 ◽  
Author(s):  
P. Girard ◽  
R. Cohen ◽  
G. Sassolas ◽  
C. Harthe ◽  
P. Cabrera ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Human Growth Hormone ◽  
Intravenous Administration ◽  
Large Range ◽  
Human Growth ◽  
Growth Hormone Releasing Factor ◽  
Normal Men

Periodic interactions of GH-releasing factor and somatostatin can augment GH release in vitro

1987 ◽  
Vol 253 (5) ◽  
pp. E508-E514
Author(s):  
J. Weiss ◽  
M. J. Cronin ◽  
M. O. Thorner
Keyword(s):  
Growth Hormone ◽  
Human Growth Hormone ◽  
Human Growth ◽  
Male Rat ◽  
Base Line ◽  
Additive Effects ◽  
Growth Hormone Releasing Factor ◽  
The Impact

Growth hormone (GH) is secreted as pulses in vivo. To understand the signals governing this periodicity, we have established a perifusion-based model of pulsatile GH release. Male rat anterior pituitaries were dispersed and perifused with pulses of human growth hormone-releasing factor-(1--40) (GHRF), with or without a continuous or discontinuous somatostatin tonus. An experiment was composed of a 1-h base-line collection followed by four 3-h cycles; each contained single or paired 10-min infusion(s) of 3 nM GHRF. In testing the impact of somatostatin, the protocol was identical except that 0.3 nM somatostatin was added 30 min into the base-line period and then was either continued throughout the study or withdrawn during the periods of GHRF infusion. GH base lines with somatostatin were lower than vehicle base lines (P less than 0.05). GHRF pulses generated consistent peaks of GH release between 200 and 300 ng. min-1. (10(7) cells)-1, and these peaks were not altered by continuous somatostatin. In contrast, withdrawal of somatostatin during GHRF administration elicited markedly higher GH peaks (P less than 0.05) and more total GH release (P less than 0.05). This response could not be accounted for by the additive effects of GHRF and somatostatin withdrawal.

Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor

2009 ◽  
Vol 39 (4) ◽  
pp. 364-374 ◽  
Author(s):  
JACOB BONGERS ◽  
EDGAR P. HEIMER ◽  
THEODORE LAMBROS ◽  
YU-CHING E. PAN ◽  
ROBERT M. CAMPBELL ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Aspartic Acid ◽  
Human Growth Hormone ◽  
Human Growth ◽  
Growth Hormone Releasing Factor

scholarly journals Non-Clinical Pharmacology and Safety Evaluation of TH9507, a Human Growth Hormone-Releasing Factor Analogue

2007 ◽  
Vol 100 (1) ◽  
pp. 49-58 ◽  
Author(s):  
Eckhardt S. Ferdinandi ◽  
Paul Brazeau ◽  
Kim High ◽  
Bryan Procter ◽  
Stephen Fennell ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Clinical Pharmacology ◽  
Human Growth Hormone ◽  
Safety Evaluation ◽  
Human Growth ◽  
Growth Hormone Releasing Factor

Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth

Nature ◽  
1985 ◽  
Vol 315 (6018) ◽  
pp. 413-416 ◽  
Author(s):  
Robert E. Hammer ◽  
Ralph L. Brinster ◽  
Michael G. Rosenfeld ◽  
Ronald M. Evans ◽  
Kelly E. Mayo
Keyword(s):  
Growth Hormone ◽  
Transgenic Mice ◽  
Human Growth Hormone ◽  
Somatic Growth ◽  
Human Growth ◽  
Growth Hormone Releasing Factor

EFFECT OF INTRAVENOUS ADMINISTRATION OF HUMAN GROWTH HORMONE ON SULPHATION FACTOR ACTIVITY IN SERUM OF HYPOPITUITARY SUBJECTS

1971 ◽  
Vol 66 (3) ◽  
pp. 491-497 ◽  
Author(s):  
Kerstin Hall
Keyword(s):  
Growth Hormone ◽  
Human Growth Hormone ◽  
Intravenous Administration ◽  
Human Growth ◽  
Significant Rise ◽  
Mean Difference ◽  
Factor Activity ◽  
The Mean

ABSTRACT Human growth hormone (HGH) administered as an iv injection of 2–4 mg to hypopituitary patients induced a rise in the levels of sulphation factor (SF) in serum. The low basal levels of SF were not changed during the first hour after HGH injection. Not until three hours after injection, when HGH values approached basal values, there was a significant rise in SF. The mean difference of SF at one and at three hours after HGH injection was 0.52 ± 0.11.

Sign in / Sign up

Export Citation Format

Share Document